Metabolic Risk Contributes to Diabetes Onset in People With HIV
MONDAY, Oct. 7, 2024 -- For people with HIV (PWH) with low-to-moderate atherosclerotic cardiovascular disease (ASCVD) risk, metabolic risk factors contribute to new-onset diabetes mellitus (DM) among those treated with pitavastatin or placebo, according to a study published online Oct. 8 in the Annals of Internal Medicine.
Kathleen V. Fitch, from Massachusetts General Hospital and Harvard Medical School in Boston, and colleagues examined the contribution of known DM risk factors to excess risk for DM with pitavastatin use among PWH in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial. Participants included 7,731 PWH aged 40 to 75 years with a low-to-moderate risk for ASCVD, without DM at study entry, who were randomly assigned to pitavastatin 4 mg daily or placebo in a 1:1 ratio.
The researchers found that in each treatment group, participants with at least three DM risk factors versus no risk factors had an increased risk for DM (incidence rate, 3.24 versus 0.34 per 100 person-years in the pitavastatin group and 2.66 versus 0.27 per 100 person-years in the placebo group). The highest incidence of DM was seen in South Asia. High body mass index, prediabetes, and metabolic syndrome components were strongly associated with new-onset DM in adjusted analyses.
"Together these data suggest the importance of implementing comprehensive risk reduction strategies for PWH with risk factors for DM, including dietary and exercise interventions," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Read this next
Prevention Strategies Developed for Cardiovascular Manifestations of COVID
FRIDAY, Sept. 26, 2025 -- Prevention strategies for cardiovascular manifestations of acute and long COVID are discussed in a report published online Sept. 18 in the European...
Diabetes Tied to Doubled Risk for Sepsis
FRIDAY, Sept. 26, 2025 -- People living with type 2 diabetes experience double the risk for incident sepsis versus matched individuals without diabetes, according to a study...
Clinical Practice Guidelines Issued for Diabetes Distress
THURSDAY, Sept. 25, 2025 -- The first clinical practice guidelines on assessment and management of diabetes distress among adults were presented at the annual meeting of the...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.